tradingkey.logo

Pacific Biosciences of California Inc <PACB.OQ> expected to post a loss of 19 cents a share - Earnings Preview

ReutersMay 6, 2025 9:17 PM
  • Pacific Biosciences of California Inc PACB.OQ PACB.O is expected to show a fall in quarterly revenue when it reports results on May 8 for the period ending March 31 2025

  • The Menlo Park California-based company is expected to report a 10.3% decrease in revenue to $34.81 million from $38.81 million a year ago, according to the mean estimate from 13 analysts, based on LSEG data.

  • ​LSEG's mean analyst estimate for Pacific Biosciences of California Inc is for a loss of 19 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," 9 "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts had fallen by about 0.5% in the last three months. ​

  • Wall Street's median 12-month price target for Pacific Biosciences of California Inc is $2.00​, above​ its last closing price of $1.11. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

-0.21

-0.21

-0.49

Missed

-138.6

Sep. 30 2024

-0.24

-0.22

-0.22

Met

2

Jun. 30 2024

-0.24

-0.23

-0.64

Missed

-175.1​

Mar. 31 2024

-0.28

-0.28

-0.29

Missed

-5.3

​​Dec. 31 2023

-0.29

-0.29

-0.31

Missed

-8.7

Sep. 30 2023

-0.34

-0.33

-0.26

Beat

20.8​

Jun. 30 2023

-0.32

-0.32

-0.28

Beat

12.7

Mar. 31 2023

-0.33

-0.33

-0.36

Missed

-8.3

This summary was machine generated May 6 at 21:17 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI